Evidence map›Paper›PMID 40637445›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2025

Cardiomyocyte YAP represses myocardial inflammation and fibrosis and restrains MEF2-regulated gene expression.

Van K Ninh, Melissa Barlow, Sidar Aydin, Cameron S Brand, Justin Yu, Jeffrey Smith, Jamie Francisco, Richard Daneman, Kevin R King, Shigeki Miyamoto and 2 more

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Integrating Senescence and Oxidative Stress in Cardiac Disease.International journal of molecular sciences · 2025
    Review
  5. Cardiomyocytes regulate Inflammation in the failing heart.American journal of physiology. Heart and circulatory physiology · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Van K NinhDepartment of Pharmacology, University of California San Diego School of Medicine, La Jolla, California, United States.ORCID 0000-0001-6017-4035
Melissa BarlowDepartment of Pharmacology, University of California San Diego School of Medicine, La Jolla, California, United States.
Sidar AydinDepartment of Pharmacology, University of California San Diego School of Medicine, La Jolla, California, United States.ORCID 0000-0001-7791-7931
Cameron S BrandDepartment of Pharmacology, University of California San Diego School of Medicine, La Jolla, California, United States.
Justin YuDepartment of Bioengineering, Jacobs School of Engineering, University of California San Diego, La Jolla, California, United States.
Jeffrey SmithDepartment of Pharmacology, University of California San Diego School of Medicine, La Jolla, California, United States.
Jamie FranciscoDepartment of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey, United States.
Richard DanemanDepartment of Pharmacology, University of California San Diego School of Medicine, La Jolla, California, United States.
Kevin R KingDepartment of Medicine, University of California San Diego School of Medicine, La Jolla, California, United States.
Shigeki MiyamotoDepartment of Pharmacology, University of California San Diego School of Medicine, La Jolla, California, United States.
Dominic P Del ReDepartment of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey, United States.
Joan Heller BrownDepartment of Pharmacology, University of California San Diego School of Medicine, La Jolla, California, United States.ORCID 0000-0002-1555-9363

Funding

Training In Cardiovascular Physiology & PharmacologyT32HL007444 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ju Chen, Robert Scott Ross · 1985 to 2026
$11.1M
PROTEIN PHOSPHORYLATION AND GROWTH FACTOR FUNCTIONR01GM051586 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROWN, JOAN HELLER · 1994 to 2024
$7.9M
The role of Neurofibromin 2 in heart failureR01HL157483 · NHLBI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Dominic P Del Re · 2022 to 2026
$2.9M
Elucidating Cell Communication Networks during Tissue Inflammation, Fibrosis, and RegenerationDP2AR075321 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KING, KEVIN R · 2018 to 2018
$2.4M
Cardiomyocyte CaM kinase II as a driver of cardiac inflammation and remodelingR01HL145459 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, MIYAMOTO, SHIGEKI · 2019 to 2022
$1.6M
Danger Signaling and Spread of Injury after Myocardial InfarctionR00HL129168 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KING, KEVIN R · 2017 to 2019
$746k
Illumina NovaSeq 6000 Sequencing SystemS10OD026929 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEPSEN, KRISTEN LYNN · 2019 to 2019
$600k
American Heart Association (AHA) 19POST34430051American Heart Association (AHA) 19TPA34910011American Heart Association (AHA) 20TPA35490150HHS | National Institutes of Health (NIH) #S10 OD026929HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R00HL129168HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL145459HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL157483HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) T32HL007444HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) DP2AR075321HHS | NIH | National Institute of General Medical Sciences (NIGMS) R01GM051586HHS | NIH | NHLBI | Division of Intramural Research (DIR) R01HL145459NHLBI NIH HHS R00 HL129168NHLBI NIH HHS R01 HL145459NHLBI NIH HHS R01 HL157483NHLBI NIH HHS T32 HL007444NIAMS NIH HHS DP2 AR075321NIGMS NIH HHS R01 GM051586NIH HHS S10 OD026929
6 · The paper itself

Abstract

Cardiomyocyte signaling through the transcriptional coactivator Yes-associated protein (YAP) has been shown to protect the myocardium against ischemic or mechanical stress. Inflammatory responses initiated in cardiomyocytes play a major role in the development of cardiac dysfunction. We tested the relationship between YAP and inflammatory gene expression using cardiomyocyte-specific YAP-knockout (KO) mice. Wild-type (WT) and KO mice were infused with angiotensin II (AngII) at 1.5 μg/kg/min and euthanized 24 h or 3 days postinfusion. YAP deletion markedly enhanced AngII-induced mRNA expression of proinflammatory cytokines and chemokines, a response that occurred selectively within cardiomyocytes. Hearts from YAP-KO mice also had increased F4/80, CD68, and Col1 staining. Single-nuclei RNA sequencing of WT and YAP-KO hearts showed significant upregulation of proinflammatory cytokines and of a range of genes, including those in the

Indexed as

Adaptor Proteins, Signal TransducingCell Cycle ProteinsMEF2 Transcription FactorsMyocarditisMyocardiumMyocytes, CardiacAngiotensin IIAnimalsCytokinesDisease Models, AnimalFibrosisGene Expression RegulationInflammation MediatorsMaleMiceMice, Inbred C57BLAdaptor Proteins, Signal TransducingAngiotensin IICell Cycle ProteinsCytokinesInflammation MediatorsMEF2 Transcription FactorsYap1 protein, mouseYAP-Signaling ProteinsangiotensincardiomyocyteinflammationMEF2YAP

Identifiers

PMID40637445
PMCPMC12338972

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.